Ellen Jansen

Ellen Jansen is the Head of the Human Challenge Trial Unit at Vaccinopolis. She obtained her Master in Biomedical Sciences from the University of Antwerp in 2006 and brings nearly 16 years of experience in clinical trial operations to the role. Before joining Vaccinopolis in 2022, Ellen served as Clinical Operations Lead of ExeVir and was responsible for determining the clinical operations strategy within the clinical development plan of a novel monoclonal antibody against COVID-19.

In previous roles, she served as Clinical Program Manager at Octimet Oncology, Clinical Project Manager at Galapagos, Global Trial Manager at Janssen Infectious Diseases and Clinical Research Associate at PPD.